Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 13,704 | 12,002 | 12,548 | 9,414 | 8,294 |
| Operating Income | -13,704 | -12,002 | -12,548 | -9,414 | -8,294 |
| Other Income | 12,784 | -14,641 | 4,607 | -8,107 | -1,885 |
| Pre-tax Income | -919 | -26,642 | -7,941 | -17,520 | -10,179 |
| Net Income Continuous | -919 | -26,642 | -7,881 | -17,520 | -10,179 |
| Net Income | $-919 | $-26,642 | $-7,881 | $-17,520 | $-10,179 |
| EPS Basic Total Ops | -0.77 | -27.33 | -12.31 | -46.55 | -27.03 |
| EPS Basic Continuous Ops | -0.77 | -27.26 | -12.25 | -46.52 | -27.14 |
| EPS Diluted Total Ops | -5.43 | -27.33 | -12.31 | -46.55 | -27.03 |
| EPS Diluted Continuous Ops | -0.74 | -27.26 | -12.25 | -46.52 | -27.14 |
| EPS Diluted Before Non-Recurring Items | -15.32 | -12.01 | -19.82 | N/A | N/A |
| EBITDA(a) | $-13,638 | $-11,913 | $-12,478 | $-9,372 | $-8,255 |